PROCEPT BioRobotics Corp (PRCT)
62.74
+1.31
(+2.13%)
USD |
NASDAQ |
May 07, 16:00
64.01
+1.27
(+2.02%)
After-Hours: 20:00
PROCEPT BioRobotics SG&A Expense (Quarterly): 39.60M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 39.60M |
| December 31, 2023 | 36.32M |
| September 30, 2023 | 32.88M |
| June 30, 2023 | 32.44M |
| March 31, 2023 | 30.13M |
| December 31, 2022 | 26.03M |
| September 30, 2022 | 24.75M |
| June 30, 2022 | 19.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 18.38M |
| December 31, 2021 | 16.27M |
| September 30, 2021 | 12.12M |
| June 30, 2021 | 12.30M |
| March 31, 2021 | 10.35M |
| December 31, 2020 | 9.134M |
| September 30, 2020 | 7.054M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
7.054M
Minimum
Sep 2020
39.60M
Maximum
Mar 2024
21.83M
Average
19.66M
Median
Jun 2022
SG&A Expense (Quarterly) Benchmarks
| Globus Medical Inc | 244.72M |
| Glaukos Corp | 61.98M |
| Integra Lifesciences Holdings Corp | 165.80M |
| Intuitive Surgical Inc | 491.50M |
| Masimo Corp | 159.90M |